Overview
Infectious posterior uveitis is an inflammatory condition affecting the posterior segment of the eye — specifically the choroid and retina — caused by an identifiable infectious agent. Unlike non-infectious (autoimmune) forms of uveitis, this condition results from direct invasion or immune response to pathogens including Toxoplasma gondii (the most common cause worldwide), cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus (VZV), Mycobacterium tuberculosis, Treponema pallidum (syphilis), and various fungi. The condition may present as focal or multifocal chorioretinitis, retinitis, retinochoroiditis, or neuroretinitis depending on the causative organism. Patients typically experience blurred vision, floaters, photophobia, and in some cases significant visual loss. The inflammation can lead to complications such as vitreous opacities, retinal detachment, macular edema, optic nerve involvement, and permanent visual impairment if not promptly treated. Immunocompromised individuals — including those with HIV/AIDS, organ transplant recipients, or patients on immunosuppressive therapy — are at particularly high risk for severe or atypical presentations. Treatment is directed at the underlying infectious cause and typically involves targeted antimicrobial therapy. For toxoplasmic retinochoroiditis, combinations of pyrimethamine, sulfadiazine, and corticosteroids are commonly used. Viral causes are treated with antiviral agents such as ganciclovir, valganciclovir, or acyclovir. Antitubercular therapy or antibiotics are employed for bacterial etiologies. Adjunctive corticosteroids may be used cautiously to control inflammation, but only in conjunction with appropriate antimicrobial coverage to avoid worsening the infection. Early diagnosis through clinical examination, serologic testing, aqueous or vitreous sampling with PCR, and imaging is essential for optimal outcomes.
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
1 eventAlimera Sciences — PHASE4
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Infectious posterior uveitis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Infectious posterior uveitis at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Infectious posterior uveitis.
Community
No community posts yet. Be the first to share your experience with Infectious posterior uveitis.
Start the conversation →Latest news about Infectious posterior uveitis
Disease timeline:
New recruiting trial: Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.
A new clinical trial is recruiting patients for Infectious posterior uveitis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Infectious posterior uveitis
What is Infectious posterior uveitis?
Infectious posterior uveitis is an inflammatory condition affecting the posterior segment of the eye — specifically the choroid and retina — caused by an identifiable infectious agent. Unlike non-infectious (autoimmune) forms of uveitis, this condition results from direct invasion or immune response to pathogens including Toxoplasma gondii (the most common cause worldwide), cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus (VZV), Mycobacterium tuberculosis, Treponema pallidum (syphilis), and various fungi. The condition may present as focal or multifocal chorioretinitis
Which specialists treat Infectious posterior uveitis?
18 specialists and care centers treating Infectious posterior uveitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.